Skip to content
Login
Insights
All Insights
In My Opinion
In Your Practice
Patient Populations
News
All News
Recent Updates
FDA Approvals
Clinical Trials
Conference Correspondent
Explore by Topic
All Topics
Cancer Types
Therapeutic Approaches
Diagnostics & Biomarkers
Multimedia
All Media
Videos
Podcasts
Sign Up
Already a member?
Log In
Insights
All Insights
In My Opinion
In Your Practice
Patient Populations
News
All News
Recent Updates
FDA Approvals
Clinical Trials
Conference Correspondent
Explore by Topic
All Topics
Cancer Types
Therapeutic Approaches
Diagnostics & Biomarkers
Multimedia
All Media
Videos
Podcasts
Sign Up
Already a member?
Log In
Login
Log In
Account Settings
Login
Log In
Account Settings
Login
Sign Up
Real Clinics. Real Patients. Real Oncology.
Home
/
Tags
/
Actinium-225
Home /
Actinium-225
Actinium-225
Actinium-225
Clinical Trials
CONVERGE-01 Shows Promising Activity With Ac-225 Rosopatamab Tetraxetan After Lu-PSMA Therapy
July 1, 2026
Clinical Trials
CONVERGE-01 Shows Promising Activity With Ac-225 Rosopatamab Tetraxetan After Lu-PSMA Therapy
July 1, 2026
News & Insights
Clinical Trials
CONVERGE-01 Shows Promising Activity With Ac-225 Rosopatamab Tetraxetan After Lu-PSMA Therapy
July 1, 2026
Podcasts
No results were found
What are you looking for?
Search
Search
POPULAR SEARCHES
Adjuvant Therapy
ASCO 2026
Biomarker Testing
Bladder Cancer